Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes

doi:10.1084/jem.163.6.1529

This Article

	Full Text (PDF, 633K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Yewdell, J. W.
	Articles by Moss, B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Yewdell, J. W.
	Articles by Moss, B.


Social Bookmarking

	What's this?

ARTICLES

Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes

JW Yewdell, JR Bennink, M Mackett, L Lefrancois, DS Lyles and B Moss

It has generally been assumed that most if not all CTL specific for vesicular stomatitis virus (VSV)-infected cells recognize the viral glycoprotein (G), an integral membrane protein abundantly expressed on infected cell surfaces. Using recombinant vaccinia viruses containing copies of cloned VSV genes to examine CTL recognition of VSV, we have confirmed that G is recognized by VSV-specific CTL. More interestingly, however, we have also found that nucleocapsid protein (N), an internal virion protein, can be detected on infected cell surfaces using mAb, and serves as a major target antigen for VSV-specific CTL. In contrast to the highly serotype-specific recognition of G, N is recognized by a major population of CTL able to lyse cells infected with either the Indiana or New Jersey VSV serotypes. Using target cells expressing a cloned MHC class I gene, we could directly show that CTL recognition of N occurs in the context of the MHC Ld molecule.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Zhao, J.-m., Wen, Y.-j., Li, Q., Wang, Y.-s., Wu, H.-b., Xu, J.-r., Chen, X.-c., Wu, Y., Fan, L.-y., Yang, H.-s., Liu, T., Ding, Z.-y., Du, X.-b., Diao, P., Li, J., Wu, H.-b., Kan, B., Lei, S., Deng, H.-x., Mao, Y.-q., Zhao, X., Wei, Y.-q. (2008). A promising cancer gene therapy agent based on the matrix protein of vesicular stomatitis virus. FASEB J. 22: 4272-4280 [Abstract] [Full Text]
Zhong, Q., Wen, Y.-J., Yang, H.-S., Luo, H., Fu, A.-F., Yang, F., Chen, L.-J., Chen, X., Qi, X.-R., Lin, H.-G., Wan, Y., Chen, X.-C., Wei, Y.-Q., Zhao, X. (2008). Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice. Ann Oncol 19: 1584-1591 [Abstract] [Full Text]
Cooper, D., Wright, K. J., Calderon, P. C., Guo, M., Nasar, F., Johnson, J. E., Coleman, J. W., Lee, M., Kotash, C., Yurgelonis, I., Natuk, R. J., Hendry, R. M., Udem, S. A., Clarke, D. K. (2008). Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice. J. Virol. 82: 207-219 [Abstract] [Full Text]
Fischer, M. A., Tscharke, D. C., Donohue, K. B., Truckenmiller, M. E., Norbury, C. C. (2007). Reduction of vector gene expression increases foreign antigen-specific CD8+ T-cell priming. J. Gen. Virol. 88: 2378-2386 [Abstract] [Full Text]
Masopust, D., Murali-Krishna, K., Ahmed, R. (2007). Quantitating the Magnitude of the Lymphocytic Choriomeningitis Virus-Specific CD8 T-Cell Response: It Is Even Bigger than We Thought. J. Virol. 81: 2002-2011 [Abstract] [Full Text]
Masopust, D., Ha, S.-J., Vezys, V., Ahmed, R. (2006). Stimulation History Dictates Memory CD8 T Cell Phenotype: Implications for Prime-Boost Vaccination. J. Immunol. 177: 831-839 [Abstract] [Full Text]
Ciavarra, R. P., Stephens, A., Nagy, S., Sekellick, M., Steel, C. (2006). Evaluation of Immunological Paradigms in a Virus Model: Are Dendritic Cells Critical for Antiviral Immunity and Viral Clearance?. J. Immunol. 177: 492-500 [Abstract] [Full Text]
Haglund, K., Leiner, I., Kerksiek, K., Buonocore, L., Pamer, E., Rose, J. K. (2002). High-Level Primary CD8+ T-Cell Response to Human Immunodeficiency Virus Type 1 Gag and Env Generated by Vaccination with Recombinant Vesicular Stomatitis Viruses. J. Virol. 76: 2730-2738 [Abstract] [Full Text]
Masopust, D., Jiang, J., Shen, H., Lefrancois, L. (2001). Direct Analysis of the Dynamics of the Intestinal Mucosa CD8 T Cell Response to Systemic Virus Infection. J. Immunol. 166: 2348-2356 [Abstract] [Full Text]
Hausmann, J., Hallensleben, W., de la Torre, J. C., Pagenstecher, A., Zimmermann, C., Pircher, H., Staeheli, P. (1999). T cell ignorance in mice to Borna disease virus can be overcome by peripheral expression of the viral nucleoprotein. Proc. Natl. Acad. Sci. USA 96: 9769-9774 [Abstract] [Full Text]
Jooss, K., Ertl, H. C.�J., Wilson, J. M. (1998). Cytotoxic T-Lymphocyte Target Proteins and Their Major Histocompatibility Complex Class I Restriction in Response to Adenovirus Vectors Delivered to Mouse Liver. J. Virol. 72: 2945-2954 [Abstract] [Full Text]
Bachmann, M., Rohrer, U., Kundig, T., Burki, K, Hengartner, H, Zinkernagel, R. (1993). The influence of antigen organization on B cell responsiveness. Science 262: 1448-1451 [Abstract]
Hosken, N., Bevan, M. (1990). Defective presentation of endogenous antigen by a cell line expressing class I molecules. Science 248: 367-370 [Abstract]
Walker, B., Flexner, C, Paradis, T., Fuller, T., Hirsch, M., Schooley, R., Moss, B (1988). HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240: 64-66 [Abstract]